Terray Therapeutics

About Terray Therapeutics

Terray Therapeutics is dedicated to revolutionizing small molecule drug discovery by integrating high-quality data at scale with generative AI. Their mission is to combine wet lab science and AI to solve the toughest therapeutic challenges, improving the speed, cost, and success rate of drug discovery and development.

Products & Services

Drug Discovery Platform:A platform designed to enhance the speed, cost, and success rate of small molecule drug discovery and development, featuring unparalleled scale with over two billion target-ligand binding measurements, precise data with high-resolution quantitative insights, closed-loop iteration cycles of less than a month, and data-rich target prioritization.

Internal Pipeline:Focused on immunology, developing small molecule therapies for internal projects.

Partnership Programs:Collaboration with large pharma and biotech to apply the platform to a wide range of challenging targets and therapeutic areas.

Specialties

Small Molecule Drug Discovery Generative AI for Drug Development High-Resolution Quantitative Data Immunology Target-Ligand Binding Measurements

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 120000000 MR: - FA: 120 million FAN: 120000000	D: 2024-10-17 FD: 2024-10-17	9 investors

Series B Latest

2024-10-17

$120.0M

9 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jacob Berlin

Chief Executive Officer

V

Vanessa Taylor

Chief Scientific Officer

F

Fez Ujjainwalla

Chief Business Officer

N

Narbe Mardirossian

Chief Technology Officer

C

Craig Schulz

Chief Platform Officer

E

Eli Berlin

Chief Financial and Operating Officer

View 134 more team members with Pro

Unlock Full Team Directory

Recent News